Tissue factor in COVID-19-associated coagulopathy
Evidence of micro-and macro-thrombi in the arteries and veins of critically ill COVID-19
patients and in autopsies highlight the occurrence of COVID-19-associated coagulopathy …
patients and in autopsies highlight the occurrence of COVID-19-associated coagulopathy …
Endothelial function and endothelial progenitor cells in systemic lupus erythematosus
The observations that traditional cardiovascular disease (CVD) risk factors fail to fully
account for the excessive cardiovascular mortality in patients with systemic lupus …
account for the excessive cardiovascular mortality in patients with systemic lupus …
A targetable pathway in neutrophils mitigates both arterial and venous thrombosis
Arterial and venous thrombosis constitutes a major source of morbidity and mortality
worldwide. Long considered as distinct entities, accumulating evidence indicates that …
worldwide. Long considered as distinct entities, accumulating evidence indicates that …
Altered platelet and coagulation function in moderate-to-severe COVID-19
To reveal if coagulopathies relate to the course of COVID-19, we examined 255 patients with
moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs …
moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs …
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system
E Hysa, CA Cutolo, E Gotelli, S Paolino… - Autoimmunity …, 2021 - Elsevier
Pathological eye involvement represents a quite common finding in a broad spectrum of
autoimmune rheumatic diseases (ARDs). Ocular signs, often occur as early manifestations …
autoimmune rheumatic diseases (ARDs). Ocular signs, often occur as early manifestations …
Antiphospholipid syndrome
M Petri - Translational Research, 2020 - Elsevier
Antiphospholipid syndrome is one of the more common acquired causes of
hypercoagulability. Its major presentations are thrombotic (arterial, venous, or …
hypercoagulability. Its major presentations are thrombotic (arterial, venous, or …
Differences in antiphospholipid antibody profile between patients with obstetric and thrombotic antiphospholipid syndrome
A Anunciación-Llunell, C Muñoz… - International journal of …, 2022 - mdpi.com
Antiphospholipid syndrome (APS) is a systemic autoimmune condition characterised by the
presence of antiphospholipid antibodies (aPL) associated with vascular thrombosis and/or …
presence of antiphospholipid antibodies (aPL) associated with vascular thrombosis and/or …
Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS)
C Solé, M Royo, S Sandoval, T Moliné… - International Journal of …, 2023 - mdpi.com
Primary antiphospholipid syndrome (PAPS) is a systemic autoimmune disease associated
with recurrent thrombosis and/or obstetric morbidity with persistent antiphospholipid …
with recurrent thrombosis and/or obstetric morbidity with persistent antiphospholipid …
Effects of anti‐beta 2‐glycoprotein 1 antibodies and its association with pregnancy‐related morbidity in antiphospholipid syndrome
JJ Fierro, M Velásquez, AP Cadavid… - American journal of …, 2022 - Wiley Online Library
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous,
arterial, or small‐vessel thrombosis and/or pregnancy‐related morbidity, associated with …
arterial, or small‐vessel thrombosis and/or pregnancy‐related morbidity, associated with …
Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature
M Taghavi, A Jabrane, L Jacobs, MDCF Mesquita… - Antibodies, 2024 - mdpi.com
Antiphospholipid antibody (aPL)-persistent positivity is frequent in hemodialysis (HD)
patients. Native arteriovenous fistula (AVF) complications such as stenosis and thrombosis …
patients. Native arteriovenous fistula (AVF) complications such as stenosis and thrombosis …